Effect of the free radical scavenger edaravone on peripheral nerve ischemia-reperfusion injury. 2009

Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
Department of Neurology, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan. hiida@yamanashi.ac.jp

We investigated the effects of edaravone, a free radical scavenger, on peripheral nerve ischemia-reperfusion injury caused by ligation of vessels supplying the sciatic and tibial nerves in rats. The control group was administered a placebo, the standard-dose group was given 3 mg/kg of edaravone intraperitoneally every 24 hours, and the low-dose group was given 1 mg/kg of edaravone. At 7 days after reperfusion, neurological and electrophysiological parameters were improved in the standard-dose group as compared with the control group. After 14 days, however, these differences were no longer observed. After 21 days, persistent edema and nerve fiber degeneration were noted in the standard-dose group, but not in the control or low-dose groups. Edaravone was effective during the early reperfusion period, but chronic inhibition of reactive oxygen species may be detrimental for nerve regeneration after ischemia-reperfusion injury. Further studies are necessary to confirm the long-term influence of edaravone.

UI MeSH Term Description Entries
D008297 Male Males
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D009412 Nerve Fibers Slender processes of NEURONS, including the AXONS and their glial envelopes (MYELIN SHEATH). Nerve fibers conduct nerve impulses to and from the CENTRAL NERVOUS SYSTEM. Cerebellar Mossy Fibers,Mossy Fibers, Cerebellar,Cerebellar Mossy Fiber,Mossy Fiber, Cerebellar,Nerve Fiber
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D000077553 Edaravone An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE. 1-Phenyl-3-methyl-5-pyrazolone,3-Methyl-1-phenyl-2-pyrazolin-5-one,Edarabone,MCI 186,MCI-186,Norantipyrine,Norphenazone,Phenylmethylpyrazolone,Radicava,1 Phenyl 3 methyl 5 pyrazolone,3 Methyl 1 phenyl 2 pyrazolin 5 one,MCI186
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
July 2008, Acta pharmacologica Sinica,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
July 2005, Transplant international : official journal of the European Society for Organ Transplantation,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
March 2010, BJU international,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
September 2008, Transplantation proceedings,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
August 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
May 2004, Kidney international,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
January 2004, International journal of molecular medicine,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
March 2010, European journal of pharmacology,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
September 2009, Journal of cardiothoracic surgery,
Haruyasu Iida, and Takamura Nagasaka, and Kazumasa Shindo, and Zenji Shiozawa
June 2012, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!